The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD).
May 26, 2025
0
4
University of Alabama at Birmingham-led researchers have refined and validated a new framework for diagnosing chronic obstructive pulmonary disease (COPD), identifying individuals at risk for severe respiratory outcomes who ...
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is no cure, progression can ...
May 14, 2025
0
35
Inhalers have been key to asthma management since the 1950s. The most common, salbutamol, comes in a familiar blue-colored inhaler (or "puffer").
May 14, 2025
0
0
People with multiple long-term physical health conditions are at a significantly greater risk of developing depression, a study shows.
May 13, 2025
0
68
For patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations and a blood eosinophil count of at least 300 cells/µL, mepolizumab leads to a lower annualized rate of moderate or severe exacerbations, ...
May 12, 2025
0
0
Individuals taking steroid tablets for more than 3 months are over 6 times more likely to be diagnosed with adrenal insufficiency than those treated with nonsteroidal anti-inflammatory drugs, according to research presented ...
May 10, 2025
0
2
From the day we're born, we know how to breathe correctly. That means letting the diaphragm—the large, thin muscle just below the rib cage—do the work of drawing air into the lungs and letting it out. It's known as diaphragmatic ...
May 8, 2025
0
3
The incidence of infection by Mycobacterium abscessus is increasing in patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other chronic pulmonary diseases, leading to an accelerated lung function ...
May 8, 2025
0
25
Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people with chronic obstructive pulmonary disease (COPD) who also require supplemental oxygen, according ...
May 1, 2025
0
0
